What is NDC 67184-0590?

67184-0590 is the product NDC for Micafungin, Micafungin 20 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Qilu Pharmaceutical Co., Ltd. It has 2 package NDCs, shown above in 10- and 11-digit form.

Qilu Pharmaceutical Co., Ltd, NDC labeler code 67184. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Micafungin?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Micafungin NDC 67184-0590 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67184-0590Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67184-0590Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67184-0590-1	6718405900167184059001	1 VIAL in 1 CARTON (67184-0590-1) / 5 mL in 1 VIALMarketed from Apr 3, 2025
67184-0590-2	6718405900267184059002	10 VIAL in 1 CARTON (67184-0590-2) / 5 mL in 1 VIALMarketed from Apr 3, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Micafungin
Generic name (nonproprietary): micafungin
Active ingredients: Micafungin — 20 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Qilu Pharmaceutical Co., LtdNDC labeler code 67184
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219273
Marketing start: Apr 3, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Lipopeptides (Chemical structure)
Identifiers: Product ID 67184-0590_0f106cca-1588-4f13-a833-662676fc85c8SPL ID 0f106cca-1588-4f13-a833-662676fc85c8SPL set ID 653f8c75-b5b8-41ea-8b33-5baad1680bdaRxCUI 861379, 861383UNII R10H71BSWGUPC 0367184059010
Pharmacologic class: Echinocandin Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467184059001 followed by a unit qualifier and the quantity

Package 67184-0590-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 10, 2024.

Indications (excerpt from the label)

Micafungin for injection is indicated for: Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older [see Clinical Studies ( 14.1 ) and Use in Specific Populations ( 8.4 )] Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age [see Use in Specific Populations ( 8.4 )] . Treatment of Esophageal Candidiasis in adult and pediatric patients 4 months of age and older [see Clinical Studies ( 14.2 )] . Prophylaxis of Candida Infections in adult and pediatric patients …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67184-0590

What is NDC 67184-0590?: 67184-0590 is the product NDC for Micafungin, Micafungin 20 mg/mL injection, powder, lyophilized, for solution, listed with the FDA by Qilu Pharmaceutical Co., Ltd. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Micafungin.
What is the active ingredient?: Micafungin.
Who is the labeler?: Qilu Pharmaceutical Co., Ltd, NDC labeler code 67184. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Micafungin?: 19 other product NDCs are listed under this name. See all Micafungin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Micafungin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Micafungin	Micafungin sodium 50 mg/1	Injection, Powder, For solutionIntravenous	Hisun Pharmaceuticals USA, Inc.	42658-022	42658-0022-0142658-0022-02
Micafungin	Micafungin sodium 100 mg/1	Injection, Powder, For solutionIntravenous	Hisun Pharmaceuticals USA, Inc.	42658-023	42658-0023-0142658-0023-02
Micafungin	Micafungin 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Glenmark Pharmaceuticals Inc., USA	68462-771	68462-0771-0168462-0771-10
Micafungin	Micafungin 20 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Glenmark Pharmaceuticals Inc., USA	68462-772	68462-0772-0168462-0772-10
Micafungin	Micafungin sodium 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Biocon Pharma Inc.	70377-075	70377-0075-91
Micafungin	Micafungin sodium 20 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Biocon Pharma Inc.	70377-076	70377-0076-91
Micafungin	Micafungin 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Qilu Pharmaceutical Co., Ltd	67184-0589	67184-0589-0167184-0589-02
Micafungin	Micafungin sodium 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1724	70710-1724-0170710-1724-06
Micafungin	Micafungin sodium 20 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1725	70710-1725-0170710-1725-06
Micafungin	Micafungin sodium 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Lifesciences Limited	70771-1683	70771-1683-0170771-1683-06

All 20 Micafungin NDCs

Other NDCs under ANDA 219273

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219273
Product	Strength	Form · route	Labeler	Product NDC
Micafungin	Micafungin 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Qilu Pharmaceutical Co., Ltd	67184-0589
Micafungin	Micafungin 10 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Glenmark Pharmaceuticals Inc., USA	68462-771
Micafungin	Micafungin 20 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Glenmark Pharmaceuticals Inc., USA	68462-772